Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)
Clinical trial NCT05655013 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05655013
- Sponsor
- Aarhus University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2027-02-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.